Reaction

Posture Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,209 reports · 91 co-occurring drugs

As of the last recalculation, Posture Abnormal appears in 3,209 FAERS reports alongside 91 co-occurring drug terms. The strongest observed disproportionality signal is ROTIGOTINE (PRR 25.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Rotigotine	56	25.5	25.6
Pimavanserin Tartrate	187	23.2	23.3
Rivastigmine	63	22.1	22.2
Levodopa	39	21.2	21.2
Carbidopa And Levodopa	137	19.5	19.6
Amantadine	42	17.8	17.9
Quetiapine Fumarate	69	15.5	15.5
Pramipexole	35	15.0	15.0
Aripiprazole Oral	92	14.8	14.9
Aripiprazole Orally Disintegrating	92	14.8	14.9
Rasagiline Mesylate	24	14.1	14.1
Phenobarbital	31	14.0	14.0
Olanzapine Pamoate	83	13.5	13.5
Memantine	27	12.9	12.9
Memantine Hydrochloride	27	12.9	12.9
Ropinirole	29	12.4	12.4
Ziprasidone	32	11.9	11.9
Olanzapine	186	11.9	11.9
Vigabatrin	26	11.7	11.7
Donepezil Hydrochloride	64	11.5	11.5
Valproate Sodium	35	11.1	11.1
Lithium Carbonate	28	10.8	10.8
Valproic Acid	50	10.4	10.5
Haloperidol	37	10.0	10.0
Clobazam	37	9.9	9.9
Haloperidol Lactate	37	9.8	9.8
Phenytoin	29	9.1	9.1
Aripiprazole	161	8.9	8.9
Quetiapine	239	8.6	8.6
Zonisamide	19	8.4	8.4
Teriparatide	135	8.1	8.1
Standardized Senna Concentrate	15	7.8	7.8
Lithium	29	7.5	7.5
Lithium Bromatum	29	7.5	7.5
Oxazepam	24	7.3	7.3
Clozapine	127	6.8	6.8
Doxepin Hydrochloride	13	6.7	6.7
Fluoxetine	67	6.6	6.6
Clonazepam	154	6.5	6.5
Doxepin	10	6.4	6.4
Botulinum Toxin Type A	12	6.3	6.3
Risperidone	124	6.3	6.3
Carbamazepine	62	6.1	6.1
Melatonin	50	6.0	6.0
Diazepam Oral Solution (Concentrate)	81	6.0	6.0
Diazepam Oral	81	6.0	6.0
Oxybutynin Chloride	8	5.9	5.9
Paroxetine Hydrochloride Hemihydrate	30	5.9	5.9
Mirtazapine	81	5.9	5.9
Paroxetine	30	5.8	5.8
Onabotulinumtoxina	67	5.7	5.7
Lacosamide	32	5.6	5.6
Divalproex Sodium	39	5.5	5.5
Cenobamate	7	5.5	5.5
Diazepam	94	5.1	5.1
Extended Phenytoin Sodium	13	5.1	5.1
Sennosides	23	5.0	5.0
Raloxifene Hydrochloride	11	4.9	4.9
Lamotrigine	94	4.7	4.7
Mirabegron	28	4.7	4.7
Lamotirigine	51	4.7	4.7
Lamotrigine Extended-Release	51	4.7	4.7
Lamotrigine Chewable Dispersible	51	4.7	4.7
Baclofen	61	4.7	4.7
Ziprasidone Mesylate	10	4.6	4.6
Lurasidone Hydrochloride	14	4.4	4.4
Norepinephrine	7	4.3	4.3
Droxidopa	14	4.2	4.2
Instalax Polyethylene Glycol 3350	7	3.7	3.7
Polyethylene Glycol 400	7	3.6	3.6
Levetiracetam In Sodium Chloride	41	3.5	3.5
Levetiracetam Oral	41	3.5	3.5
Levetiracetam Injection	41	3.5	3.5
Polyethylene Glycol 3350	49	3.4	3.4
Brexpiprazole	8	3.1	3.1
Paliperidone	11	3.1	3.1
Interferon Beta-1B	9	3.1	3.1
Paliperidone Palmitate	15	3.0	3.0
Suvorexant	6	3.0	3.0
Dalfampridine	33	3.0	3.0
Asenapine Maleate	4	3.0	3.0
Fesoterodine Fumarate	5	3.0	3.0
Teriflunomide	20	2.9	2.9
Natalizumab	73	2.6	2.6
Vibegron	3	2.4	2.4
Iohexol	3	2.3	2.3
Valbenazine	9	2.3	2.3
Alpelisib	3	2.2	2.2
Avapritinib	4	2.1	2.1
Dimethyl Fumarate	28	1.5	1.5
Palivizumab	3	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.